Recent studies have revealed that the activation of PTEN-induced AKT signaling, alongside the suppression of the WNT/β-catenin pathway, is essential for modulating the ratio of LGR5+ cells in liver cancer, suggesting that dual modulation may represent a promising novel approach for the treatment of liver cancer. This evidence concerns the gene AKT1 and liver cancer.